Barinthus Biotherapeutics (BRNS) Return on Sales (2020 - 2025)
Barinthus Biotherapeutics' (BRNS) quarterly Return on Sales came in at 0.04% in Q4 2025, little changed YoY from 0.04% in Q4 2024, and up 12.49% on a QoQ basis from 0.05% in Q3 2025.
Barinthus Biotherapeutics (BRNS) Return on Sales (2020 - 2025) Analysis & Trends
Barinthus Biotherapeutics (BRNS) has 6 years of Return on Sales data on file, last reported at 0.04% in Q4 2025.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.04% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.04% (changed 0.0% YoY) and the FY2024 annual result came in at 0.04%, up 87.0% from the prior year.
- Return on Sales climbed to 0.04% in Q4 2025, from 0.05% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 168.19% in Q4 2021 to a low of 4.82% in Q2 2021.
- A 5-year average of 9.11% and a median of 0.05% in 2025 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2021 — Return on Sales jumped 16855 bps — and 2022, when it plunged 16822 bps.
- Tracing BRNS's Return on Sales over 5 years: stood at 168.19% in 2021, then tumbled by 100 bps to 0.03% in 2022, then tumbled by 2694 bps to 0.92% in 2023, then jumped by 96 bps to 0.04% in 2024, then declined by 9 bps to 0.04% in 2025.
- The last three Return on Sales figures came in at 0.04% (Q4 2025), 0.05% (Q3 2025), and 0.04% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 0.00% |
| 10 | Barinthus Biotherapeutics | 25.73 Mn | 25.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.04% |
| Sep 30, 2025 | -0.05% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | -0.01% |
| Mar 31, 2024 | -2.12% |
| Dec 31, 2023 | -0.92% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.71% |
| Mar 31, 2023 | -0.39% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 168.19% |
| Sep 30, 2021 | -3.71% |
| Jun 30, 2021 | -4.82% |
| Mar 31, 2021 | -0.41% |
| Dec 31, 2020 | -0.36% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.09% |